Please login to the form below
ICU
This page shows the latest ICU news and features for those working in and with pharma, biotech and healthcare.
AZ licenses pneumonia mAb to Aridis Pharmaceuticals for $11m upfront
This also corresponded with a reduction in the number of days patients needed in ICU and hospital. ... Previous data, published in the Lancet Infectious Diseases in June, suggested that the mAb was not effective at reducing pneumonia caused by
Latest news
-
WHO recommends ‘life-saving’ IL-6 inhibitors for severe COVID-19
On average, patients treated with these drugs were able to leave the ICU around a week earlier than those not receiving these treatments.
-
FDA fast-tracks review of Incyte’s Jakafi for chronic GVHD
In this trial, the number of patients who died or required mechanical ventilation due to respiratory failure or ICU care by day 29 was 12% for Jakafi-treated patients and
-
PharmaMar’s cancer drug has ‘potent preclinical efficacy’ against COVID-19
At first we are not targeting ICU patients, there will be hospitalised patients, but doctors are collaborating with us to identify the different phases a sick person goes through, and determine
-
UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19
On average, patients treated with these drugs were able to leave the ICU around a week earlier than those not receiving these treatments.
-
Two drugs found to reduce mortality in severe COVID-19 patients
be in an intensive care unit (ICU). ... On average, patients treated with these drugs were able to leave the ICU around a week earlier than those not receiving these treatments.
More from news
Approximately 2 fully matching, plus 14 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2016
1, 120. Hospira / Pfizer (US). ICU Medical (US). Asset Acquisition.
-
An effective commercial model for cancer care
According to studies, adding palliative care consultation to the standard of care for patients avoids unnecessary tests or treatment and reduces costs associated with ICU and hospital stays.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics
patients in ICU settings with mild and severe disease).
-
Washington HealthCare Careers
Candidates post resumes and review fresh job listings related to nurse manager, occupational therapist, pharmacist, physical therapist, RN ICU intensive care, CCU critical care, speech therapist jobs while recruiters source the
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- Amgen reports positive results for Otezla in psoriatic arthritis
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Seqera Labs and Genomics England partner to progress genomic research
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s RSV vaccine approved by FDA for older adults
No results were found
PMHub
Say Communications
We focus on what matters most…. Driven by insight, expertise and fresh thinking, our award-winning communications programmes are designed to...
Latest intelligence
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
- Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
- Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...
